12:00 AM
 | 
Apr 24, 2000
 |  BC Week In Review  |  Clinical News  |  Preclinical Results

CytRx preclinical data

In a transgenic mouse model of ACS, 80 percent of Flocor-treated animals survived versus <20 percent...

Read the full 56 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >